The Research: What Studies Have Found Important compliance note: The following section describes research findings from published studies
This has called for new emerging strategies for improved bioavailability that include chemical modifications to stabilize the peptide, use of enzyme inhibitors, linkage to absorption enhancers, and packaging peptides using nanoparticles
Recalls & Warnings March 23, 2026 FDA Warns Consumers Not to Use ULTRA ADVANC3 Joint Supplements On February 26, 2026, the FDA warned consumers not to purchase or use ULTRA ADVANC3 and ULTRA ADVANC3 GOLD, products promoted for joint pain relief, because FDA testing found that they contain undeclared dexamethasone, diclofenac, and methocarbamol, which are not permitted in
From welcoming new businesses and enhancing public spaces to delivering engaging programming and fostering cultural collaborations, each effort contributed to a more vibrant, connected, and thriving community
